Covid-19 Updates

COVID-19 Vaccine Planning in DeKalb County

For a more detailed list of Phase 1A and 1B, visit the Illinois Department of Public Health’s Website.

COVID-19 Vaccine Notification

By clicking on the buttons below, you are able to be added to a distribution list and will be notified when you are eligible to receive the COVID-19 vaccine. Notification will typically via come via email, make sure you check your spam!

Information updated as of 1/15/20

DeKalb County Health Department (DCHD) has been working diligently in accordance with the DCHD Mass Vaccination Plan and the IDPH Mass Vaccination Plan to prepare and execute the distribution of COVID-19 vaccines upon receiving initial shipments. DCHD has provided COVID-19 vaccine to over 1,000 Phase 1A workers, including EMS Providers, School Nurses, Healthcare Providers not affiliated with Northwestern Medicine (NM), Dental Providers, and Behavioral Health Providers at three clinics over the last two weeks. Additionally, DCHD has transferred 1,000 doses to NM Hospitals locally for vaccination of their healthcare workers.

“These clinics have been a community effort using our existing Emergency Operations Plan and partnerships. They would not be possible without the existing collaborative relationships in our community,” said DCHD Public Health Administrator, Lisa Gonzalez.

Long-term care facilities (LTCF) in DeKalb County have also begun to receive vaccines through the Pharmacy Partnership Program. This program is a direct partnership between LTCF and pharmacies.

At this time, vaccines are still limited. DCHD continues to plan additional mass-vaccination clinics for Phase 1A and over the next few weeks, we will be transitioning into Phase 1B priority groups. Please be patient with us as our goal is to vaccinate all people who choose to receive the vaccine. At this time, clinic dates cannot be scheduled far in advance as vaccine allotment has not been consistent from week to week. In collaborating with our partners, we are using a multifaceted approach for our vaccine administration. This multifaceted approach includes mass vaccination clinics, but also includes the use of clinical strike teams to vaccinate smaller priority groups.

Current Distribution Considerations

  • When FDA first authorizes or approves the use of one or more COVID-19 vaccines, there will be a limited supply. This would mean that not everyone will be able to be vaccinated right away.
  • While the supply is limited, certain groups (e.g. healthcare workers and long term care residents) will be prioritized to receive vaccine, based on national guidance.
  • DCHD has been working with health care and community partners to increase our ability to quickly distribute a large amount of COVID-19 vaccine, as it becomes available.
  • Supplies will increase over time, and it is anticipated all adults should be able to get vaccinated later in 2021. As more vaccine distributed by the federal government, COVID-19 vaccine will be available through additional vaccination providers, including doctors’ offices, retail pharmacies, hospitals, and federally qualified health centers.

Groups Considered for Early Vaccination if Supply is Limited

Although this information will be released by the Advisory Committee on Immunization Practices (ACIP) after the Emergency Use Authorization (EUA) is issued, these priority groups could include:

  • Healthcare Personnel (Phase 1a) continue to be on the front line of the nation’s fight against this deadly pandemic. By providing critical care to those infected with the virus that causes COVID-19, many healthcare personnel have a high risk of being exposed to and getting sick with COVID-19. Healthcare personnel who get COVID-19 can also spread the virus to their patients seeking care for medical conditions that, in turn, increase their patients’ risk for severe COVID-19 illness. Early vaccine access is critical to ensuring the health and safety of this essential workforce of approximately 21 million people, protecting not only them but also their patients, communities, and the broader health of our country.
  • Residents in Long Term Care facilities (Phase 1a) are at high risk for infection, severe disease, and death from COVID-19.  Prevention may reduce hospital utilization.
  • Workers in essential and critical industries are considered part of America’s critical infrastructure. Current data show that many of these workers are at increased risk for getting COVID-19. Early vaccine access is critical not only to protect them but also to maintain the essential services they provide U.S. communities.
  • People with certain underlying medical conditions are at increased risk for severe COVID-19 illness, regardless of their age. Severe illness means that the person with COVID-19 may require hospitalization, intensive care, or a ventilator to help them breathe, or that they may even die. Early vaccine access is critical to ensuring the health and safety of this population that is disproportionately affected by COVID-19.
  • Among adults, the risk for severe illness and death from COVID-19 increases with age, with older adults at highest risk. Early vaccine access is critical to help protect this population that is disproportionately affected by COVID-19.

Vaccine Safety

  • The U.S. vaccine safety system ensures all vaccines are as safe as possible. Safety is a top priority. Currently, clinical trials are evaluating investigational COVID-19 vaccines with many thousands of study participants to generate scientific data and other information for the FDA to determine their safety and effectiveness.
  • If the FDA determines a vaccine meets its safety and effectiveness standards, it can make these vaccines available for use in the U.S. by approval or Emergency Use Authorization (EUA). After the FDA makes its determination, ACIP will review the available data in order to make vaccine recommendations to the CDC. ACIP will then recommend vaccine use. After a vaccine is authorized or approved for use, vaccine safety monitoring systems will watch for adverse events (possible side effects). CDC is working to expand safety surveillance through new systems and additional information sources, as well as enhancing existing safety monitoring systems.


Information on the Moderna COVID-19 Vaccine

Illinois Department of Public Health: Information on the COVID-19 Vaccine


Region 1 COVID-19 Vaccine FAQ

COVID-19 Client Administration Form

Important Update/Actualización Importante

Please be patient with us, we are experiencing extremely high call volume at this time. To reach a specific program, please call the program’s direct phone line for assistance. For a listing of program phone numbers, click here. Your call will be returned within 24 business hours.

If you are calling about the COVID-19 vaccine, you need to sign-up for our notification system in order to be notified when you are eligible. Please click here to sign-up. If you have specific questions about the COVID-19 vaccine, please email

Note: All services are currently by appointment only.


Tenga paciencia con nosotros, estamos experimentando un volumen de llamadas extremadamente alto en este momento. Para comunicarse con un programa específico, llame a la línea telefónica directa del programa para obtener ayuda. Para obtener una lista de los números de teléfono del programa, haga clic aquí. Su llamada será devuelta dentro de 24 horas en horario de oficina. Si llama por la vacuna COVID-19, debe registrarse en nuestro sistema de notificación para que se le notifique cuando sea elegible. Por favor, haga clic aquí para inscribirse. Si tiene preguntas específicas sobre la vacuna COVID-19, envíe un correo electrónico a

Nota: Todos los servicios son actualmente solo con cita previa.